#United States #Seattle #New England Biolabs #cfRNA #cfDNA

New England Biolabs Showcases Groundbreaking Advances in Molecular Diagnostics at AMP 2026

As the Association for Molecular Pathology (AMP) Annual Meeting & Expo kicks off in Seattle, Washington, New England Biolabs (NEB) is set to make a significant impact with its latest technological advancements in molecular diagnostics. The event, scheduled from November 10-15, 2026, offers a unique platform for NEB to highlight its cutting-edge solutions, specifically focusing on the analysis of cell-free DNA (cfDNA) and cell-free RNA (cfRNA).

NEB, a prestigious name in enzymology and molecular biology for over 50 years, aims to equip researchers with vital reagents and workflows that enhance the detection and analysis of genetic information derived from blood samples. This approach is particularly pertinent to modern medical investigations, especially in the realms of diagnosis and treatment monitoring for various diseases.

Betsy Young, Ph.D., NEB’s Senior Product Marketing Manager for Next Generation Sequencing, expressed enthusiasm about the opportunity that AMP presents. “It’s an excellent chance to connect with the molecular pathology community, to gather insights on their pressing scientific challenges, and to enhance our collaborative efforts to streamline their research processes,” she remarked. Such interactions are crucial as NEB strives to ensure that its offerings are not only innovative but also tailored to the scientists’ needs.

Significant Contributions to Molecular Diagnostics

At the heart of NEB's presentation is a workshop scheduled for November 11, entitled One Sample, Many Insights: Multiomic Profiling in cfDNA and cfRNA Samples. This session will delve into the nuances of extracting and analyzing multiple forms of biological information from scant clinical samples, providing invaluable insights into disease mechanisms.

Nicole M. Nichols, Ph.D., Executive Director of Applications and Product Development at NEB, underscored the transformative potential of utilizing cell-free nucleic acids. “These materials provide a minimally invasive glimpse into disease biology. To harness their full capacity, researchers require effective workflows that facilitate the recovery and detailed analysis of complex information,” she stated. The workshop promises to reveal integrated methodologies that utilize both Monarch® Nucleic Acid Purification and NEBNext® NGS Library Preparation, allowing scientists to confidently examine complementary mutation, methylation, and gene expression signals from their samples.

Interactive Engagement with the Scientific Community

In addition to the corporate workshop, NEB is keen on engaging with attendees through poster presentations that investigate pressing scientific queries. These presentations will showcase NEB’s dedication to advancing methodologies critical to molecular analysis. Highlights include:

• - Poster #ST176: NEBNext Enzymatic Solutions Enable DNA Methylation Profiling of Highly Damaged Patient-Matched Tumor-Normal Samples. Presented by Margaret R. Heider, Ph.D.
• - Poster #TT065: A New, High-Fidelity PCR Master Mix with Broad NGS Workflow Compatibility and Superior Performance in High-Sensitivity Applications. Also presented by Margaret R. Heider, Ph.D.

Through these discussions and findings, NEB aims to share knowledge and enhance collaborative research in molecular diagnostics.

Commitment to Scientific Excellence

For more than half a century, New England Biolabs (NEB) has been synonymous with innovation in molecular biology research. The organization has dedicated itself to creating and refining tools that empower scientists across academia and industry. Their commitment is reflected not just in advancing technology but also in supporting extensive research initiatives that facilitate groundbreaking discoveries in diagnostics and therapeutics.

For those attending the AMP Annual Meeting, NEB encourages interaction at their booth (#922), where team members from Applications and Product Development will be present to discuss how NEB can support ongoing research endeavors.

If you are unable to attend the AMP Expo this year, NEB encourages visiting their official website for a comprehensive overview of their products and innovations in molecular biology.

About New England Biolabs

Headquartered in Ipswich, Massachusetts, New England Biolabs (NEB) has established itself as an industry leader in the discovery and production of enzyme technologies aimed at molecular biology. With an expansive global presence, NEB is devoted to fostering scientific inquiry, improving the research landscape, and addressing the complex challenges faced by modern molecular epidemiology.